A phase II multi-center, single arm, safety and efficacy study of MBG453 in combination with azacitidine and venetoclax for the treatment of Acute Myeloid Leukemia (AML) in adult patients unfit for chemotherapy

Project: Research

Project Details

StatusActive
Effective start/end date25/11/2124/11/26

Keywords

  • phase 2 study
  • treatment safety
  • treatment efficacy
  • myeloid leukemia